Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-00885706 add-on to esomeprazole in proton pump inhibitor poor responders with gastro-esophageal reflux disease
2007-001487-67Phase 2Completed
- Sponsor
- Pfizer
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in gastroesophageal reflux disease (GERD) comparing PF-00885706 dose arm(s) + esomeprazole with Placebo + esomeprazole (2 arms). Primary endpoint: Complete resolution of heartburn and regurgitation. Started Aug 2007; status: completed.
02
Drugs
PF-00885706
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on 2007-001487-67.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001487-67.